Both in vitro and in vivo Treg migration was effectively blocked by a novel, small molecule antagonist of CCR4, CCR4-351.
[PLoS Pathogens]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Immune Regulation News EBV+ Tumors Exploit Tumor Cell-Intrinsic and -Extrinsic Mechanisms to Produce Regulatory T...
